| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Celldex Therapeutics, Inc. | EXECUTIVE VP & CSO | Incentive Stock Option (right to buy) | 93,000 | 05 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CLDX | Celldex Therapeutics, Inc. | 05 Jun 2025 | 1 | $0 | 4 | EXECUTIVE VP & CSO | 09 Jun 2025, 16:14 |
| CLDX | Celldex Therapeutics, Inc. | 13 Jun 2024 | 1 | $0 | 4 | EXECUTIVE VP & CSO | 17 Jun 2024, 16:13 |
| CLDX | Celldex Therapeutics, Inc. | 15 Jun 2023 | 1 | $0 | 4 | EXECUTIVE VP & CSO | 20 Jun 2023, 16:14 |
| CLDX | Celldex Therapeutics, Inc. | 07 Dec 2022 | 3 | -$575,740 | 4 | EXECUTIVE VP & CSO | 09 Dec 2022, 15:07 |
| CLDX | Celldex Therapeutics, Inc. | 16 Jun 2022 | 1 | $0 | 4 | EXECUTIVE VP & CSO | 17 Jun 2022, 16:11 |
| CLDX | Celldex Therapeutics, Inc. | 17 Jun 2021 | 1 | $0 | 4 | Executive VP & CSO | 21 Jun 2021, 16:26 |